1Lallo A, Billard V, Bourgain JL. A comparison of propofol and remifentanil target-controlled infusions to facilitate fiber- optic nasotracheal intubation. Anesth Analg, 2009, 108(3) : 852-857.
2Hu R, Liu JX, Jiang H. Dexrnedetomidine versus remifen- tanil sedation during awake fiberoptic nasotracheal intuba- tion: a double-blinded randomized controlled trial. J Anesth, 2013, 27(2): 211-217.
3Vennila R, Hall A, All M, et al. Remifentanil as single a- gent to facilitate awake fibreoptic intubation in the absence of premeditation. Anaesthesia, 2011,66(5) : 368-372.
4Shapiro A, Zohar E, Zaslansky R, et al. The frequency and timing of respiratory depression in 1524 postoperative pa- tients treated with systemic or neuraxial morphine. J Clin Anesth, 2005, 17(7) : 537-542.
5Bailey PL, Egan TD, Stanley TH. Intravenous opioid anes- thetics. In: Miller RD. Atlesthesia. Fifth edition, Churchill livingstone, 2001:273-376.
6Mingo OH, Ashpole KJ, Irving CJ, et al. Remifentanil seda- tion for awake fibreoptie intubation with limited application of local anaesthetic in patients for elective head and neck surger- y. Anaesthesia, 2008, 63(10): 1065-1069.
7Neidhart G, Bremerieh DH, Kessler P. Fiberoptic intubation during remi{entanil propo{ol sedation. Anaesthesist (Ger- man), 2001, 50(4): 242-247.
8Groeben H, Mitzner W, Brown RH. Effects of the a2 adre- noceptor agonist dexrnedetomidine on bronchoconstriction in dogs. Anesthesiology, 2004, 100(2): 359-363.
9Kanaya N, Gable B, Wickley PJ, et al. Experimental condi- tions are important determinants of cardiac inotropic effects of propofol. Anesthesiology, 2005, 103(5) : 1026-1034.
10Kunisawa T, Nagashima M, Hanada S, et al. Awake intuba- tion under sedation using target-controlled infusion of dexrne detomidine: five case reports. J Anesth, 2010, 24 ( 5 ) : 789-792.
